Skip to main content

Day: March 10, 2022

Seanergy Maritime Holdings Corp. Reports Record Fourth Quarter 2021 Financial Results and Declares Dividend of $0.05 Per Share

Initiates Quarterly Dividend, Declares Special Dividend &Completes New Buyback of Convertibles totalling $10 million in 2022 Highlights of the Fourth Quarter of 2021:EPS basic: $0.12 and Adjusted EPS1 basic: $0.16 in Q4 2021 EPS diluted: $0.11 and Adjusted EPS1 diluted: $0.14 in Q4 2021 Net revenues: $56.7 million in Q4 2021, as compared to $21.3 million in Q4 2020, up 166% Net Income: $20.6 million in Q4 2021, as compared to net loss of $2.3 million in Q4 2020 Adjusted Net Income1: $27.9 million in Q4 2021, as compared to an adjusted net loss of $2.3 million in Q4 2020 EBITDA1: $31.5 million in Q4 2021, as compared to $8.3 million in Q4 2020, up 280% Adjusted EBITDA1: $38.8 million in Q4 2021, as compared to $8.3 million in Q4 2020, up 367%Highlights of Full Year 2021:EPS basic: $0.27 and Adjusted EPS1 basic: $0.35 in Q4...

Continue reading

Ocuphire Pharma to Present at Oppenheimer Annual Healthcare Conference

FARMINGTON HILLS, Mich., March 10, 2022 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders, today announced that Mina Sooch, MBA, Founder and CEO will present a corporate overview at the Oppenheimer 32nd Annual Healthcare Conference on Wednesday, March 16 at 8:00-8:30 AM EDT.Oppenheimer 32nd Annual Healthcare Conference – March 15-17, 2022     Title: Ocuphire Pharma (OCUP) Company PresentationDate: Wednesday, March 16, 2022Time: 8:00 AM EDTPresenter: Mina Sooch, CEOWebcast Link: Register here  If you are interested in arranging a 1X1 meeting request or listening live or to a replay of the company presentation, please contact your bank conference...

Continue reading

NTG Nordic Transport Group A/S – Notice to convene the Annual General Meeting 2022

Company announcement no. 02 – 22 10 March 2022 NTG Nordic Transport Group A/S – Notice to convene the Annual General Meeting 2022 The Annual General Meeting of NTG Nordic Transport Group A/S will be held on Thursday, 7 April 2022, at 10:00 am (CEST) at Glostrup Park Hotel, Hovedvejen 41, 2600 Glostrup, Denmark. The notice to convene the Annual General Meeting including Appendix 1 is attached. Additional information For additional information, please contact:Christian D. Jakobsen, Group CFO                                    +45 42 12 80 99 ir@ntg.comJohan Lønberg, Group General Counsel  +45 81 77 44 56jlo@ntg.comAttachments NTG Annual General Meeting 2022 – notice to convene incl. appendixAttachmentsNTG Annual General Meeting 2022 – notice to convene incl. appendixCompany...

Continue reading

Inuvo to Present at the Maxim Group 2022 Virtual Growth Conference, March 28-30

LITTLE ROCK, Ark., March 10, 2022 (GLOBE NEWSWIRE) — Inuvo, Inc. (NYSE American: INUV), a leading provider of marketing technology powered by Artificial Intelligence (AI), today announced that Richard Howe, CEO, is scheduled to present at the Maxim Group 2022 Virtual Growth Conference taking place March 28th through the 30th. To register for the conference please visit; CONFERENCE REGISTRATION. A webcast of the presentation will be available throughout the event. To schedule a one-on-one meeting with management, please contact your Maxim Group representative directly, or send an email to Investor Relations at Valter@KCSA.com. About InuvoInuvo®, Inc. (NYSE American: INUV) is a market leader in Artificial Intelligence built for advertising. Its IntentKey AI solution is a first-of-its-kind proprietary and patented technology capable...

Continue reading

Troika Media Group Signs a Firm Commitment for a $75 Million Senior Secured Credit Facility with a Multibillion-Dollar Institutional Investor to Fund the Acquisition of Converge Direct LLC

Financial Highlights:Converge Direct, LLC and its affiliated businesses (collectively, “Converge”) generated approximately $300 million of revenue, $23 million of adjusted EBITDA and approximately $21 million of net income for the year ended December 31, 2021 Estimated combined adjusted EBITDA over $27 million for CY 2022 Significantly accretive to adjusted earnings per shareFollowing the closing, it is anticipated that the majority of the combined business’ revenue will be recurringCantor Fitzgerald & Co. is serving as sole debt placement agent to Troika Media Group in connection with the transaction.LOS ANGELES, CA, March 10, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Troika Media Group, Inc. (Nasdaq:TRKA) (“TMG” or “Company”), a brand consultancy and marketing innovations company that provides...

Continue reading

Koncernårsrapport 2021

Bestyrelsen har dags dato behandlet og godkendt årsrapporten for 2021 for Fast Ejendom Danmark A/S. Resultatet af ejendommenes drift blev realiseret med 48,5 mio. kr. (2020: 34,8 mio. kr.). I kombination med værdireguleringer af investeringsejendomme på 83,2 mio. kr. (2020: 19,6 mio. kr.), administrationsomkostninger på 11,9 mio. kr. (2020: 11,1 mio. kr.), finansieringsomkostninger på 9,6 mio. kr. (2020: 8,9 mio. kr.) samt skat på 33,2 mio. kr. (2020: 8,5 mio. kr.) blev årets resultat efter skat 77,0 mio. kr. (2020: 25,9 mio. kr.). Den i 2020 konstaterede større efterspørgsel, særligt efter lager- og logistikejendomme, er fortsat igennem 2021. Udover den positive udvikling i udlejningsaktiviteterne drevet af en stigende efterspørgsel fra potentielle lejere, har der tillige været en positiv tendens i udviklingen af markedslejen. Ligeledes...

Continue reading

Form 8 (OPD) Allied Minds Plc

Opening Position Disclosure FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Allied Minds plc  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest...

Continue reading

Zealand Pharma: Significant Advancement of Clinical Pipeline and Building Commercial Momentum. Key Data for Glepaglutide and Dasiglucagon Programs Expected in 2022.

Company announcement – No. 7 / 2022 Zealand Pharma: Significant Advancement of Clinical Pipeline and Building Commercial Momentum. Key Data for Glepaglutide and Dasiglucagon Programs Expected in 2022. Full Year Results for 2021 Copenhagen, March 10, 2022 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, announced financial results for the 12-month period from January 1 to December 31, 2021. In 2021, a number of significant milestones were accomplished by Zealand Pharma, including the U.S. Food and Drug Administration (FDA) approval of Zegalogue® (dasiglucagon) injection for the treatment of severe hypoglycemia in patients with diabetes aged six and above, and the product’s subsequent commercial...

Continue reading

Sodexo and University Hospitals Expand and Extend Their Partnership

Gaithersburg, Md., March 10, 2022 (GLOBE NEWSWIRE) — Sodexo, a food and facilities management company, announced today the expansion and extension of Sodexo’s largest integrated services healthcare client in the U.S., University Hospitals (UH). Sodexo provides UH with a breadth of services including patient nutrition and retail food (UH’s cafeterias, Wolfgang Puck’s at UHCMC, and coffee kiosks such as Einstein’s), facilities and construction management, and healthcare technology management. “Sodexo is proud to be a trusted partner to University Hospitals Health System,” said Stuart Winters, CEO, Healthcare, North America, Sodexo. “Our organizations’ values are very much aligned and as a result, we’re able to work seamlessly as a team with the benefit of patients and staff top of mind.”   “We continue to value our partnership with...

Continue reading

Orbit International Corp. Reports 2021 Year End Results

COMPANY RECOMMENCES ITS QUARTERLY CASH DIVIDEND PAYMENT AND ANNOUNCES CASH DIVIDEND OF $0.01 PER COMMON SHARE FOR THE FIRST QUARTER OF 2022 2021 Net Income of $3,246,000 ($0.93 per diluted share) v. $641,000 ($0.18 per diluted share) in Prior Year Period 2021 EBITDA, As Adjusted, of $3,499,000 ($1.01 per diluted share) v. $921,000 ($0.26 per diluted share) in Prior Year Period Exclusive of PPP Loan Forgiveness and Acquisition Costs Relating to the Panel Products Acquisition, 2021 Net Income was $1,991,000 ($0.57 per diluted share) and EBITDA, As Adjusted was $2,244,000 ($0.65 per diluted share) Fourth Quarter 2021 Net Income of $204,000 ($0.06 per diluted share) v. $153,000 ($0.04 per diluted share) in Prior Year Period Fourth Quarter 2021 EBITDA, As Adjusted, of $244,000 ($0.07 per diluted share) v. $236,000 ($0.07 per diluted share)...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.